To Our Paitents

Approved by the FDA for clinical use in 2002, buprenorphine has been proven to be effective in the treatment of opioid addiction.
The first opioid treatment medication approved for this use, buprenorphine can be prescribed by a medical provider and filled at any pharmacy offering flexibility and freedom from daily program visits.

A long acting medication, a once daily dose prevents cravings and withdrawals for 24 hours or more.

MAKE AN APPOINTMENT

Know The Risks

• Every day, more than 130 people in the United States die after overdosing on opioids.
• In 2017, more than 47,000 Americans died as a result of an opioid overdose, including prescription opioids, heroin and illicitly manufactured fentanyl.
• In 2017, an estimated 1.7 milliion people in the United States suffered from substance use disorders related to prescription opioid pain relievers and 652,000 suffered from heroin use disorder.
• The total “economic burden” of prescription opioid misuse in the United States alone is $78.5 billion a year, including the costs of healthcare, lost productivity, addiction treatment and criminal justice involvement.
• An estimated 4 to 6 percent who misuse prescription opioids transition to heroin.
• About 80 % of people who use heroin misused prescription opioids first.
• Opioid overdoses increased 30% from July 2016 through September 2017 in 52 areas of 45 states.
• The increase in injection drug use has contributed to the spread of infectious diseases including HIV and Hepatitis C.
• Almost 21 million Americans have at least one addiction, yet only 10% of them receive treatment.
• More than 90% of people who have an addiction started to drink alcohol or use drugs before they were 18 years old.

CONTACT US